These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

910 related articles for article (PubMed ID: 31421869)

  • 1. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.
    Yoh T; Cauchy F; Le Roy B; Seo S; Taura K; Hobeika C; Dokmak S; Farges O; Gelli M; Sa Cunha A; Adam R; Uemoto S; Soubrane O
    Surgery; 2019 Dec; 166(6):975-982. PubMed ID: 31421869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma.
    Sposito C; Ratti F; Cucchetti A; Ardito F; Ruzzenente A; Di Sandro S; Maspero M; Ercolani G; Di Benedetto F; Guglielmi A; Giuliante F; Aldrighetti L; Mazzaferro V
    J Hepatol; 2023 Feb; 78(2):356-363. PubMed ID: 36328332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
    Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
    World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic Impact of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma: a Propensity Score-Matched Study.
    Kim SH; Han DH; Choi GH; Choi JS; Kim KS
    J Gastrointest Surg; 2019 Mar; 23(3):538-544. PubMed ID: 30112702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of lymphadenectomy in node-negative intrahepatic cholangiocarcinoma: A multicenter, retrospectively study.
    Chen C; Su J; Wu H; Qiu Y; Song T; Mao X; He Y; Cheng Z; Zhai W; Li J; Geng Z; Tang Z
    Eur J Surg Oncol; 2023 Apr; 49(4):780-787. PubMed ID: 36404249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series.
    Li DY; Zhang HB; Yang N; Quan Y; Yang GS
    World J Gastroenterol; 2013 Dec; 19(47):9084-91. PubMed ID: 24379635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution.
    Kim DH; Choi DW; Choi SH; Heo JS; Kow AW
    Surgery; 2015 Apr; 157(4):666-75. PubMed ID: 25682172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of surgical treatment for hepatolithiasis-associated intrahepatic cholangiocarcinoma: A retrospective study in a single institution.
    Xiao J; Zhu J; Liu Z; Wan R; Li Y; Xiao W
    J Cancer Res Ther; 2017; 13(5):756-760. PubMed ID: 29237899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should lymphadenectomy performed routinely in patients with primary intrahepatic cholangiocarcinoma undergoing curative hepatectomy? A retrospective cohort study with propensity-score matching analysis.
    Huang S; Song JL; Li B; Yi PS; Yang J
    BMC Surg; 2023 Nov; 23(1):364. PubMed ID: 38036995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
    Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
    Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and feasibility of laparoscopic liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma: a propensity score-based case-matched analysis from a single institution.
    Ratti F; Cipriani F; Ariotti R; Gagliano A; Paganelli M; Catena M; Aldrighetti L
    Surg Endosc; 2016 May; 30(5):1999-2010. PubMed ID: 26194257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database.
    Clark CJ; Wood-Wentz CM; Reid-Lombardo KM; Kendrick ML; Huebner M; Que FG
    HPB (Oxford); 2011 Sep; 13(9):612-20. PubMed ID: 21843261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
    Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
    Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and feasibility of laparoscopic versus open liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma.
    Wu J; Han J; Zhang Y; Liang L; Zhao J; Han F; Dou C; Zhang Y; Liu J; Wu W; Hu Z; Zhang C
    Biosci Trends; 2020 Nov; 14(5):376-383. PubMed ID: 32921695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MEGNA Score and Preoperative Anemia are Major Prognostic Factors After Resection in the German Intrahepatic Cholangiocarcinoma Cohort.
    Schnitzbauer AA; Eberhard J; Bartsch F; Brunner SM; Ceyhan GO; Walter D; Fries H; Hannes S; Hecker A; Li J; Oldhafer K; Rahbari N; Rauchfuss F; Schlitt HJ; Settmacher U; Stavrou G; Weitz J; Lang H; Bechstein WO; Rückert F
    Ann Surg Oncol; 2020 Apr; 27(4):1147-1155. PubMed ID: 31646454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the possible therapeutic benefit of lymphadenectomy among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma.
    Vitale A; Moustafa M; Spolverato G; Gani F; Cillo U; Pawlik TM
    J Surg Oncol; 2016 May; 113(6):685-91. PubMed ID: 26936676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma.
    Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Hamba H; Tanaka H; Kinoshita H
    World J Surg; 2001 Jul; 25(7):865-9. PubMed ID: 11572025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
    Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.
    Li SQ; Liang LJ; Hua YP; Peng BG; He Q; Lu MD; Chen D
    Chin Med J (Engl); 2009 Oct; 122(19):2286-91. PubMed ID: 20079127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
    Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
    J Surg Oncol; 2007 Aug; 96(2):160-5. PubMed ID: 17443744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.